Work

Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.7_suppl.1

Authors: Razvan Cristescu, Robin Mogg, Mark Ayers, Andrew Albright, Erin Murphy, Jennifer Yearley, Xinwei Sher, Xiaoqiao Liu, Michael Nebozhyn, Jared K. Lunceford, Andrew K. Joe, Jonathan Cheng, Elizabeth R. Plimack, Patrick Alexander Ott, Tanguy Y. Seiwert, Terrill K McClanahan, Andrey Loboda, David Ross Kaufman

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Fox Chase Cancer Center, Dana-Farber Cancer Institute, University of Chicago

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2798095019

Cites:

Cited by: 15

Related to: 10